Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Disease and meta-analysis and CYP2D6[original query] |
|---|
| Parkinson's disease and CYP2D6 polymorphism in Asian populations: A meta-analysis. Neuroepidemiology 0 22 (6): 357-61. Persad Amanda S, Stedeford Todd, Tanaka Seigo, Chen Liping, Banasik Mar |
| Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis. Breast cancer research and treatment 2010 Aug 122 (3): 609-17. Seruga Bostjan, Amir Eit |
| CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Clinical pharmacology and therapeutics 2014 Feb 95 (2): 216-27. Province M A, Goetz M P, Brauch H, Flockhart D A, Hebert J M, Whaley R, Suman V J, Schroth W, Winter S, Zembutsu H, Mushiroda T, Newman W G, Lee M-T M, Ambrosone C B, Beckmann M W, Choi J-Y, Dieudonné A-S, Fasching P A, Ferraldeschi R, Gong L, Haschke-Becher E, Howell A, Jordan L B, Hamann U, Kiyotani K, Krippl P, Lambrechts D, Latif A, Langsenlehner U, Lorizio W, Neven P, Nguyen A T, Park B-W, Purdie C A, Quinlan P, Renner W, Schmidt M, Schwab M, Shin J-G, Stingl J C, Wegman P, Wingren S, Wu A H B, Ziv E, Zirpoli G, Thompson A M, Jordan V C, Nakamura Y, Altman R B, Ames M M, Weinshilboum R M, Eichelbaum M, Ingle J N, Klein T E, |
| CYP2D6 phenotypes and Parkinson's disease risk: a meta-analysis. Journal of the neurological sciences 2014 Jan 336 (1-2): 161-8. Lu Yu, Peng Qiliu, Zeng Zhiyu, Wang Jian, Deng Yan, Xie Li, Mo Cuiju, Zeng Jie, Qin Xue, Li Sh |
| Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis. Journal of the neurological sciences 2014 Aug 343 (1-2): 15-22. Lu Yu, Qin Xue, Li Shan, Zhang Xiaolian, He Yu, Peng Qiliu, Deng Yan, Wang Jian, Xie Li, Li Taijie, Zeng Zhi |
| CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis. PloS one 2013 8 (12): e84413. Lu Yu, Mo Cuiju, Zeng Zhiyu, Chen Siyuan, Xie Yantong, Peng Qiliu, He Yu, Deng Yan, Wang Jian, Xie Li, Zeng Jie, Li Shan, Qin X |
| Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis. CNS drugs 2016 Jun . Xiao Tingting, Jiao Bin, Zhang Weiwei, Tang Beisha, Shen |
| NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis. Expert opinion on drug metabolism & toxicology 2016 May . Jiménez-Jiménez Félix Javier, Alonso-Navarro Hortensia, García-Martín Elena, Agúndez José A |
| Association between Functional CYP2D6 Polymorphisms and Susceptibility to Autoimmune Diseases: A Meta-Analysis. Immunological investigations 2016 Oct 1-14. Lee Young Ho, Bae Sang-Che |
| Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection. Neurochemical research 2017 9 42 (12): 3353-3361. Ur Rasheed Mohd Sami, Mishra Abhishek Kumar, Singh Mahendra Prat |
| A Simulation Study to Compare the Treatment Effect of Tamoxifen by CYP2D6 Genotypes and Third-Generation Aromatase Inhibitors. Journal of clinical pharmacology 2017 Apr . Park Gwan Cheol, Jung Jin-A, Bae Kyun-Seop, Lim Hyeong-Se |
| The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis. OncoTargets and therapy 2017 10 5429-5437. Lu Junjun, Li He, Guo Peng, Shen Rui, Luo Yingbin, Ge Qiao, Shi Wenfei, Li Yan, Zhu Weika |
- Page last reviewed:Feb 1, 2024
- Content source: